Fate Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of FATE for the last quarter is 6.77 M USD, and it's 251.79% higher compared to the previous quarter. The net income of Q2 24 is -38.43 M USD.